相关实验视频
Updated: Jun 4, 2025

08:36
In Vitro Assay to Study Tumor-macrophage Interaction
Published on: August 1, 2019
7.5K
拥抱多样性:巨细胞在癌症中的复杂性
Jan Hochstadt1, Sarai Martínez Pacheco1, María Casanova-Acebes1
1Cancer Immunity Laboratory, Molecular Oncology Program, Spanish National Cancer Research Center (CNIO), Madrid, Spain.
Trends in cancer
|January 3, 2025
概括
瘤相关巨细胞 (TAMs) 是重要的髓状细胞,塑造瘤进化. 本综述探讨了TAM多样性和可塑性,通过将单细胞表型与复杂的生理信号相结合,以更深入地了解它们的生物学.
科学领域:
- 免疫学 免疫学 免疫学
- 癌症生物学 癌症生物学
- 细胞生物学 细胞生物学
背景情况:
- 巨细胞,特别是瘤相关巨细胞 (TAMs),是骨髓状细胞,是瘤进展的组成部分.
- 通过复杂的细胞相互作用和功能程序,TAMs积极影响瘤的进化.
- 了解TAM的异质性和可塑性对于推进癌症研究至关重要.
研究的目的:
- 审查TAM的多样性,考虑单细胞表型和生理信号.
- 在瘤微环境中整合有关TAM复杂性和可塑性的当前知识.
- 突出需要采用能够捕捉 TAM 生物学全方位的模型.
主要方法:
- 对癌症中巨细胞生物学现有文献的综述.
- 从单细胞和空间转录组学研究中分析数据.
- 整合影响TAM状态和功能的生理信号.
主要成果:
- 在它们的状态和功能方面,TAM表现出显著的纵向和局部异质性.
- TAM具有超出简单细胞增殖的瘤雕塑能力.
- 目前的模型往往缺乏足够的复杂性来完全代表TAM生物学.
结论:
- 对TAM多样性的全面理解需要整合单细胞表型与复杂的生理线索.
- 对TAM可塑性的进一步研究对于开发有效的癌症疗法至关重要.
- 需要先进的模型来充分阐明TAMs的基本功能程序.
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K
Immune Surveillance by NK Cells and Phagocytes
1.3K
Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
1.3K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K

